342 related articles for article (PubMed ID: 15134822)
1. Aldosterone target organ protection by eplerenone.
Rudolph AE; Rocha R; McMahon EG
Mol Cell Endocrinol; 2004 Mar; 217(1-2):229-38. PubMed ID: 15134822
[TBL] [Abstract][Full Text] [Related]
2. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
Moore TD; Nawarskas JJ; Anderson JR
Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934
[TBL] [Abstract][Full Text] [Related]
3. Eplerenone in the treatment of chronic heart failure.
Krum H; Liew D
Expert Rev Cardiovasc Ther; 2004 May; 2(3):315-20. PubMed ID: 15151479
[TBL] [Abstract][Full Text] [Related]
4. New biology of aldosterone, and experimental studies on the selective aldosterone blocker eplerenone.
Funder JW
Am Heart J; 2002 Nov; 144(5 Suppl):S8-11. PubMed ID: 12422135
[No Abstract] [Full Text] [Related]
5. Recent studies with eplerenone, a novel selective aldosterone receptor antagonist.
McMahon EG
Curr Opin Pharmacol; 2001 Apr; 1(2):190-6. PubMed ID: 11714095
[TBL] [Abstract][Full Text] [Related]
6. Do diuretics and aldosterone receptor antagonists improve ventricular remodeling?
Pitt B
J Card Fail; 2002 Dec; 8(6 Suppl):S491-3. PubMed ID: 12555163
[TBL] [Abstract][Full Text] [Related]
7. Eplerenone: a selective aldosterone blocker.
Stier CT
Cardiovasc Drug Rev; 2003; 21(3):169-84. PubMed ID: 12931252
[TBL] [Abstract][Full Text] [Related]
8. Role of the selective aldosterone receptor blockers in arterial hypertension.
Sierra C; Ruilope LM
J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):23-5. PubMed ID: 15136969
[TBL] [Abstract][Full Text] [Related]
9. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
Pitt B; Remme W; Zannad F; Neaton J; Martinez F; Roniker B; Bittman R; Hurley S; Kleiman J; Gatlin M;
N Engl J Med; 2003 Apr; 348(14):1309-21. PubMed ID: 12668699
[TBL] [Abstract][Full Text] [Related]
10. More hope for heart failure. Findings suggest expanded use of aldosterone-blockers.
Aaronson K
Health News; 2003 May; 9(5):4. PubMed ID: 12739453
[No Abstract] [Full Text] [Related]
11. Role of a selective aldosterone blocker in mice with chronic heart failure.
Wang D; Liu YH; Yang XP; Rhaleb NE; Xu J; Peterson E; Rudolph AE; Carretero OA
J Card Fail; 2004 Feb; 10(1):67-73. PubMed ID: 14966777
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone and aldosterone antagonism in cardiovascular disease: focus on eplerenone (Inspra).
Stier CT; Koenig S; Lee DY; Chawla M; Frishman WH
Heart Dis; 2003; 5(2):102-18. PubMed ID: 12713678
[TBL] [Abstract][Full Text] [Related]
13. Eplerenone--a novel selective aldosterone blocker.
Zillich AJ; Carter BL
Ann Pharmacother; 2002 Oct; 36(10):1567-76. PubMed ID: 12243608
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone antagonism and congestive heart failure: a new look at an old therapy.
Thohan V; Torre-Amione G; Koerner MM
Curr Opin Cardiol; 2004 Jul; 19(4):301-8. PubMed ID: 15218387
[TBL] [Abstract][Full Text] [Related]
15. The role of aldosterone in heart failure and the clinical benefits of aldosterone blockade.
Dawson A; Davies JI; Struthers AD
Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):29-36. PubMed ID: 15038411
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure.
Suzuki G; Morita H; Mishima T; Sharov VG; Todor A; Tanhehco EJ; Rudolph AE; McMahon EG; Goldstein S; Sabbah HN
Circulation; 2002 Dec; 106(23):2967-72. PubMed ID: 12460880
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure.
Adams KF
Am J Health Syst Pharm; 2004 May; 61 Suppl 2():S4-13. PubMed ID: 15160833
[TBL] [Abstract][Full Text] [Related]
18. The role of aldosterone receptor blockade in the management of cardiovascular disease.
Liew D; Krum H
Curr Opin Investig Drugs; 2002 Oct; 3(10):1468-73. PubMed ID: 12431020
[TBL] [Abstract][Full Text] [Related]
19. Selective aldosterone blockade with eplerenone in patients with congestive heart failure.
Salam AM
Expert Opin Investig Drugs; 2003 Aug; 12(8):1423-7. PubMed ID: 12882627
[TBL] [Abstract][Full Text] [Related]
20. [Selective aldosterone blocking in heart failure. Eplerenone reduces the risk after infarction].
MMW Fortschr Med; 2003 Oct; 145(44):42-3. PubMed ID: 14655506
[No Abstract] [Full Text] [Related]
[Next] [New Search]
